antibody drug conjugate

FDA Lifts Hold on Mersana’s Antibody-Drug Conjugate Following Patient Death
BioSpace
Thu, 11/2/23 - 11:42 am
Mersana Therapeutics
XMT-2056
clinical trials
FDA
antibody drug conjugate
Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Biopharma Reporter
Mon, 08/7/23 - 10:14 am
Daiichi Sankyo
antibody drug conjugate
oncology
Seagen
Roche
After chat with FDA, ImmunoGen delays pivotal top-line data on blood cancer ADC to 2024
Fierce Biotech
Wed, 08/31/22 - 10:31 am
Immunogen
antibody drug conjugate
pivekimab sunirine
blood cancer